Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The STEP (Semaglutide Treatment Effect in People with obesity) trial program showed average weight reductions of approximately 15% of initial body weight over 68 weeks in individuals without diabetes, with somewhat lower reductions (about 9-10%) in those with type 2 diabetes
It achieves this by modulating MMPs and by attracting immune cells and endothelial cells to injury sites
Baseline characteristics, such as age, sex, BMI, hemoglobin A1c, comorbid conditions and medications, were balanced between groups
Wearing light, breathable clothing can also make a big difference
US$ 25.94
US$ 20.88
US$ 24.28
US$ 25.50
